TC
MREO

Tejara Capital’s Mereo BioPharma MREO Stock Holding History

Tejara Capital’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$647K Hold
2,037,520
– – 0.27% 56
2026
Q1 		$672K Sell
2,037,520
-122,161
-6% -$52.4K 0.22% 68
2025
Q4 		$900K Buy
2,159,681
+252,837
+13% +$481K 0.21% 56
2025
Q3 		$3.93M Sell
1,906,844
-523,593
-22% -$965K 2.05% 19
2025
Q2 		$6.59M Sell
2,430,437
-90,887
-4% -$219K 3.05% 6
2025
Q1 		$5.67M Buy
2,521,324
+204,239
+9% +$578K 2.19% 10
2024
Q4 		$8.11M Sell
2,317,085
-512,905
-18% -$2.02M 5.31% 5
2024
Q3 		$11.6M Buy
2,829,990
+214,532
+8% +$887K 5.54% 2
2024
Q2 		$9.42M Buy
2,615,458
+145,274
+6% +$471K 3.42% 9
2024
Q1 		$8.15M Sell
2,470,184
-1,242,945
-33% -$4.21M 3% 10
2023
Q4 		$8.58M Buy
3,713,129
+498,128
+15% +$953K 3.59% 10
2023
Q3 		$4.15M Buy
3,215,001
+177,030
+6% +$235K 2.35% 15
2023
Q2 		$4.01M Buy
3,037,971
+602,165
+25% +$698K 1.97% 14
2023
Q1 		$1.72M Buy
2,435,806
+247,200
+11% +$222K 0.88% 34
2022
Q4 		$1.64M Buy
+2,188,606
New +$1.8M 0.95% 33

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM

Tejara Capital's MREO Position: Q2 2026 in Review

Tejara Capital held its Mereo BioPharma (MREO) position steady in Q2 2026 at 2,037,520 shares worth $647K. The position accounts for 0.27% of the portfolio, ranked #56.

Tejara Capital first reported a position in MREO in Q4 2022 and has held it in 15 quarters since. The position peaked at $11.6M in Q3 2024. 61 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

  • Tejara Capital held 2,037,520 shares of Mereo BioPharma worth $647K as of Q2 2026.
  • Tejara Capital left its Mereo BioPharma share count unchanged in Q2 2026.
  • Mereo BioPharma made up 0.27% of Tejara Capital's portfolio in Q2 2026, its #56 holding.
  • Tejara Capital first reported a position in Mereo BioPharma in Q4 2022 and has held it in 15 quarters since.
  • Tejara Capital's Mereo BioPharma position peaked at $11.6M in Q3 2024.
  • 61 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on Tejara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.